Literature DB >> 22451315

Validation of a latent variable representing the dementing process.

Donald R Royall1, Raymond F Palmer, Sid E O'Bryant.   

Abstract

The cognitive correlates of functional status are essential to dementia case-finding. Nevertheless, cognitive performance is a generally weak predictor of functional outcomes. We have employed structural equation models to explicitly distinguish functional status, and therefore "dementia-relevant" variance in cognitive task performance (i.e., δ) from the variance that is unrelated to a dementing process (i.e., g'). Together, g' + δ encompass Spearman's g. Although δ represents only a small fraction of the total variance in cognitive task performance, it is more strongly associated with dementia status than is g'. In this study, we validate δ in a well characterized Alzheimer's disease cohort, the Texas Alzheimer's Research and Care Consortium. Our approach results in "error free" continuous variables. This suggests that δ can serve as a dementia specific endophenotype. As a result, future studies may be able to associate δ with inflammatory and genetic biomarkers.

Entities:  

Mesh:

Year:  2012        PMID: 22451315     DOI: 10.3233/JAD-2012-120055

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  17 in total

1.  The δ latent dementia phenotype in the uniform data set: Cross-validation and extension.

Authors:  Brandon E Gavett; Vanessa Vudy; Mary Jeffrey; Samantha E John; Ashita S Gurnani; Jason W Adams
Journal:  Neuropsychology       Date:  2014-08-25       Impact factor: 3.295

2.  The default mode network may be the key substrate of depressive symptom-related cognitive changes.

Authors:  Donald R Royall; Raymond F Palmer; Eric D Vidoni; Robyn A Honea
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

3.  The default mode network and related right hemisphere structures may be the key substrates of dementia.

Authors:  Donald R Royall; Raymond F Palmer; Eric D Vidoni; Robyn A Honea; Jeffrey M Burns
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

4.  The effectiveness and unique contribution of neuropsychological tests and the δ latent phenotype in the differential diagnosis of dementia in the uniform data set.

Authors:  Samantha E John; Ashita S Gurnani; Cara Bussell; Jessica L Saurman; Jason W Griffin; Brandon E Gavett
Journal:  Neuropsychology       Date:  2016-11       Impact factor: 3.295

5.  Transcriptomics of cortical gray matter thickness decline during normal aging.

Authors:  P Kochunov; J Charlesworth; A Winkler; L E Hong; T E Nichols; J E Curran; E Sprooten; N Jahanshad; P M Thompson; M P Johnson; J W Kent; B A Landman; B Mitchell; S A Cole; T D Dyer; E K Moses; H H H Goring; L Almasy; R Duggirala; R L Olvera; D C Glahn; J Blangero
Journal:  Neuroimage       Date:  2013-05-24       Impact factor: 6.556

6.  The Role of Alzheimer's and Cerebrovascular Pathology in Mediating the Effects of Age, Race, and Apolipoprotein E Genotype on Dementia Severity in Pathologically-Confirmed Alzheimer's Disease.

Authors:  Brandon E Gavett; Samantha E John; Ashita S Gurnani; Cara A Bussell; Jessica L Saurman
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

7.  Exportation and Validation of Latent Constructs for Dementia Case Finding in a Mexican American Population-based Cohort.

Authors:  Donald R Royall; Raymond F Palmer; Kyriakos S Markides
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2017-10-01       Impact factor: 4.077

8.  Serum interleukin (IL)-15 as a biomarker of Alzheimer's disease.

Authors:  Ram J Bishnoi; Raymond F Palmer; Donald R Royall
Journal:  PLoS One       Date:  2015-02-24       Impact factor: 3.240

9.  "Executive functions" cannot be distinguished from general intelligence: two variations on a single theme within a symphony of latent variance.

Authors:  Donald R Royall; Raymond F Palmer
Journal:  Front Behav Neurosci       Date:  2014-10-24       Impact factor: 3.558

10.  Latent variables may be useful in pain's assessment.

Authors:  Donald R Royall; Ricardo Salazar; Raymond F Palmer
Journal:  Health Qual Life Outcomes       Date:  2014-01-30       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.